Immutep (IMMP) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Immutep Revenue Highlights


Latest Revenue (Y)

$3.51M

Latest Revenue (Q)

$2.11M

Immutep Revenue by Period


Immutep Revenue by Year

DateRevenueChange
2023-06-30$3.51M1957.72%
2022-06-30$170.37K-95.71%
2021-06-30$3.97M-47.00%
2020-06-30$7.49M5255.80%
2019-06-30$139.78K-94.69%
2018-06-30$2.63M-37.69%
2017-06-30$4.22M2311.59%
2016-06-30$175.05K-91.64%
2015-06-30$2.09M-33.35%
2014-06-30$3.14M-21.60%
2013-06-30$4.01M163.51%
2012-06-30$1.52M100.00%
2011-06-30--100.00%
2010-06-30$523.73K100.00%
2009-06-30-100.00%
2008-06-30--

Immutep generated $3.51M in revenue during NA 2023, up 1957.72% compared to the previous quarter, and up 133.27% compared to the same period a year ago.

Immutep Revenue by Quarter

DateRevenueChange
2023-12-31$2.11M15.96%
2023-06-30$1.82M7.99%
2022-12-31$1.69M889.34%
2022-06-30$170.37K-91.82%
2021-12-31$2.08M26.20%
2021-06-30$1.65M-25.42%
2020-12-31$2.21M1744.57%
2020-06-30$119.95K-98.37%
2019-12-31$7.37M5169.99%
2019-06-30$139.78K-93.87%
2018-12-31$2.28M-12.79%
2018-06-30$2.62M-38.26%
2017-12-31$4.24M67.70%
2017-06-30$2.53M100.00%
2017-03-31--100.00%
2016-12-31$1.59M-427476.08%
2016-06-30$-372.00100.00%
2016-03-31--100.00%
2015-12-31$1.26M663.76%
2015-06-30$165.58K-85.85%
2014-12-31$1.17M323.39%
2014-06-30$276.32K-84.15%
2013-12-31$1.74M990.16%
2013-06-30$159.96K-89.26%
2012-12-31$1.49M100.00%
2012-06-30--

Immutep generated $2.11M in revenue during Q2 2024, up 15.96% compared to the previous quarter, and up 127.91% compared to the same period a year ago.

Immutep Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
VECTVectivBio$27.34M$676.00K
IMMPImmutep$3.51M$2.11M
CWBRCohBar--
AVROAVROBIO--
CNSPCNS Pharmaceuticals--
ZURAZura Bio--
ELEVElevation Oncology--
ZVSAZyVersa Therapeutics--
OCEAOcean Biomedical--
ENVBEnveric Biosciences--
EFTReFFECTOR Therapeutics--

IMMP Revenue FAQ


Immutep's yearly revenue for 2023 was $3.51M, representing an increase of 1957.72% compared to 2022. The company's yearly revenue for 2022 was $170.37K, representing a decrease of -95.71% compared to 2021. IMMP's yearly revenue for 2021 was $3.97M, representing a decrease of -47.00% compared to 2020.

Immutep's quarterly revenue for Q2 2024 was $2.11M, a 15.96% increase from the previous quarter (Q4 2023), and a 1.35% increase year-over-year (Q2 2022). The company's quarterly revenue for Q4 2023 was $1.82M, a 7.99% increase from the previous quarter (Q2 2023), and a 10.30% increase year-over-year (Q4 2021). IMMP's quarterly revenue for Q2 2023 was $1.69M, a 889.34% increase from the previous quarter (Q4 2022), and a -23.82% decrease year-over-year (Q2 2021).

Immutep's revenue growth rate for the last 3 years (2021-2023) was -11.65%, and for the last 5 years (2019-2023) was 2407.99%.